Efficacy of vitamin D3 as add-on therapy in patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial

✍ Scribed by Joost Smolders; Raymond Hupperts; Frederik Barkhof; Luigi M.E. Grimaldi; Trygve Holmoy; Joep Killestein; Peter Rieckmann; Myriam Schluep; Reinhold Vieth; Ulrike Hostalek; Lizette Ghazi-Visser; Manolo Beelke

• Book ID: 119304080
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 355 KB
• Volume: 311
• Category: Article
• ISSN: 0022-510X
• DOI: 10.1016/j.jns.2011.04.013